Market size was valued at US$ 1.26 billion in 2024 and is projected to reach US$ 2.89 billion by 2032, at a CAGR of 12.6% during the forecast period 20252032
Report Studies
• The global MEMS Biosensors Market size was valued at US$ 1.26 billion in 2024 and is projected to reach US$ 2.89 billion by 2032, at a CAGR of 12.6% during the forecast period 2025-2032.
• MEMS (Micro-Electro-Mechanical Systems) biosensors are miniaturized devices that integrate biological sensing elements with microelectronic components. These advanced sensors detect and measure biological or chemical substances through precise mechanical movements at microscopic scales, enabling applications in healthcare diagnostics, environmental monitoring, and industrial process control. Key types include potentiometric, electrochemical, thermal, and bulk acoustic wave-based MEMS biosensors.
Email: help@semiconductorinsight.com
By Type:
• The market is segmented based on type into:
• Potentiometric Mems Biosensors
• Bulk Acoustics Wave Based Mems Sensor
• Electrochemical Mems Biosensor
• Thermal Mems-Based Biosensor
• Others
By Application:
• The market is segmented based on application into:
• Medical • Food and Beverage
• Environmental Monitoring
• Industrial • Others
• Abbott Laboratories (U.S.)
• Bosch Sensortec GmbH (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Dexcom, Inc. (U.S.)
• Medtronic plc (Ireland)
• Ascensia Diabetes Care (Switzerland)
• F. Hoffmann-La Roche Ltd (Switzerland)
